Status:
TERMINATED
Medicine Adherence and Effects on Transplants With Pilloxa's Electronic Pillbox
Lead Sponsor:
Pilloxa
Conditions:
Kidney Transplant; Complications
Liver Transplant; Complications
Eligibility:
All Genders
Phase:
NA
Brief Summary
Poor adherence to medication among patients with chronic diseases is a major problem. A patient group where the adherence to prescribed medications is extremely important are organ transplanted patien...
Eligibility Criteria
Inclusion
- Patient had an organ (liver or kidney) transplanted.
- Patient who wishes to participate in the study and who is able to understand, read, write and give written informed consent in the Swedish or English language. For persons under the age of 18, the guardians must understand, read, write and give written informed consent in the Swedish or English language.
- Ongoing daily immunosuppressive medication that is expected to continue during the study period.
- Handles medication by herself or, in the case of children, that medication is handled by the guardian.
- The patients doses of immunosuppressants fits into the chambers of the product.
- The patient's medicine ordination is not expected to change more often than once weekly.
- Owns and uses a compatible smartphone, option for underage children that guardians hold a compatible smartphone.
Exclusion
- Suffers from dementia, neurological disease or other cognitive impairment which causes problems in understanding instructions or managing medication independently.
- Physical inability to use the product as intended.
Key Trial Info
Start Date :
November 29 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 12 2020
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03848585
Start Date
November 29 2018
End Date
October 12 2020
Last Update
September 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Patient Area Transplantation, Karolinska University Hospital
Huddinge, Sweden